STAT3 Inhibitor
Asset
Binds directly to activated STAT3 to inhibit its activity.
- Stage
- Preclinical
- Modality
- Small molecule
- Target
- STAT3
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Cancer
Preclinical, altaytherapeutics.com, 10 Oct 2026
Inflammatory diseases
Preclinical, altaytherapeutics.com, 10 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.